Dr. Utkan Demirci received his bachelor’s degree (summa cum laude) from the University of Michigan, Ann Arbor, his master’s degrees in Electrical Engineering in 2001 and in Management Science and Engineering in 2005, and his doctorate in Electrical Engineering in 2005 all from Stanford University. In 2007, he was recruited to the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School to serve as an Assistant Professor of Medicine. Dr. Demirci also served at the Harvard-MIT Health Science and Technology, Massachusetts Institute of Technology (MIT). In 2013, Dr. Demirci was promoted to Associate Professor of Medicine at Harvard Medical School.
Dr. Demirci has been recognized by various awards including NSF CAREER Award, IEEE EMBS Early Career Achievement Award, IEEE EMBS Translational Science Award as well as the Chinese International Young Scientist Award by the National Science Foundation of China. He was recognized by Junior Chamber International (JCI) globally among the ten outstanding young persons of the world (TOYP) in “Medical Innovation” in 2009. In 2008, he was given Department of Medicine, Harvard Medical School-Young Investigator Award. In 2006, the MIT Technology Review selected Dr. Demirci to TR-35 as one of the world’s top 35 young innovators under the age of 35. Furthermore, Dr. Demirci received the Coulter Foundation Early Career Award in Biotechnology (Phase I in 2007, and Phase II in 2009); Nano-Biotechnology Award by The National Science Council of Turkey and The Turkish Industrialists’ and Businessmen’s Association; CIMIT Award; MIT Deshpande Center Award. Dr. Demirci has successfully created two start-up companies over the past 3 years that use technologies developed in his laboratory.
Dr. Demirci has published over 100 peer-reviewed journal publications in journals including Nature Communications, PNAS, Advanced Materials, ACS Nano, Nano Today, Biomaterials, Lab-chip, Nanomedicine, and advanced materials, in addition to 130 conference abstracts and proceedings, 14 book chapters, and 4 edited books. Further, he has given over 100 national and international presentations including invited and keynote at various academic, governmental, and industrial institutions. During the past 2 years, his research has been cited over 1600 times. His work has been highlighted in Nature News, Wired Magazine, Nature Photonics, Reuters News, MIT Technology Review Magazine, AIP News, BioTechniques, and Biophotonics. He has served multiple times as an associate editor and a theme chair for various conferences including IEEE Engineering in Medicine and Biology Society (IEEE EMBS) and Biomedical Engineering Society (BMES).
Dr. Demirci’s laboratory has a strong and scholarly track record of multiple creative innovations. His work focuses on creating innovative micro/nanoscale technologies to understand, diagnose, monitor, and treat disease conditions. His expertise is uniquely positioned at the interface between engineering and medicine to address fundamental biological and clinical questions. In this interdisciplinary space at the convergence of engineering, biology, medicine, his work interfaces cells in miniature systems that enable applications for point-of-care (POC) diagnosis, monitoring of infectious diseases, and early detection of cancer. These applications are unified around his expertise to push the limits of cell manipulation by establishing broadly applicable platforms to detect and investigate diseases thoroughly and provide solutions for real-world challenges by forging the link between technology, biology, and medicine.